Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Akahane, N. Horita, T. Takezawa, T. Arai, M. To, Y. To (Tokyo, Japan). Serum immunoglobulin level is a useful marker for the risk of opportunistic infection in steroid dependent patients with chronic inflammatory airway diseases. Eur Respir J 2011; 38: Suppl. 55, 3351

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021 Year: 2022 Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Expression of stress genes in circulating leucocytes: response to the systemic inflammation in patients with severe pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 231s Year: 2004 The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Leptin as a specific marker of risk factors in severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 The content of IgE and circulating immune complexes (CIC) in pregnant women with exacerbation of chronic simple bronchitis due to cytomegalovirus infection Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Coexisting chronic diseases in COPD – cause of elevated level of C-reactive protein? Source: Annual Congress 2007 - COPD and comorbidity Year: 2007